PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells
Kauko, Otto, O’Connor, Caitlin M., Kulesskiy, Evgeny, Sangodkar, Jaya, Aakula, Anna, Izadmehr, Sudeh, Yetukuri, Laxman, Yadav, Bhagwan, Padzik, Artur, Laajala, Teemu Daniel, Haapaniemi, Pekka, Momeny,Volume:
10
Langue:
english
Journal:
Science Translational Medicine
DOI:
10.1126/scitranslmed.aaq1093
Date:
July, 2018
Fichier:
PDF, 693 KB
english, 2018